Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Conclusions Use of SGLT2is is probably cost-effective among all people with type 2 diabetes, especially among those with pre-existing CVD
The drug will likely become pricier via self-pay as doses increase, though Novo Nordisk hasn't disclosed those prices yet
RDs find themselves counseling patients who are curious or take these medications and often are peppered with questions about their actions, side effects, and implications for short- and long-term use
Chlorophyll metabolism in higher plants VI
Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis
US$ 27.30
US$ 23.63
US$ 22.34
US$ 27.01
